MedPath

Impact of Respiratory Physiotherapy in the Management of Infectious Pleural Effusion

Not Applicable
Completed
Conditions
Infection
Pleural Diseases
Interventions
Other: Chest physiotherapy
Registration Number
NCT02359383
Lead Sponsor
Hospital de Granollers
Brief Summary

Chest physiotherapy (CP) facilitates the absorption of fluid in the pleural cavity and reduces the formation of fibrous adhesions in patients with pleural infection, allowing a faster clinical, functional and radiological improve. The aim of the study is to determine if the CP associated with conventional medical treatment (CT) improves functional sequelae secondary to pleural infectious.

Detailed Description

This is a multicenter, prospective and randomized trial. Objective: To determine if the Chest physiotherapy (CP) associated with conventional medical treatment (CT) improves functional sequelae secondary to pleural infectious disease, defined as an increased of 15% in Vital Functional Capacity (VFC). Adult patients with diagnosis of pleural infection will be included and randomized into two branches: control group - only CT and interventional one - CT plus CP.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Diagnosis of infectious pleural effusion
  • Failure to meet any exclusion criteria.
Exclusion Criteria
  • Hemothorax.
  • Malignant pleural effusion.
  • Severe comorbidities (end-stage disease, neuromuscular diseases, etc)
  • Previous ribcage and/or diaphragmatic pathology.
  • Pregnancy.
  • Previous respiratory rehabilitation program completed.
  • Prior pleural pathology

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Chest Physiotherapy groupChest physiotherapyConventional medical treatment plus Chest Physiotherapy
Primary Outcome Measures
NameTimeMethod
Change in improving lung function3 months

To determine if Respiratory Physiotherapy (RP) associated with conventional medical treatment (CT) improves functional sequelae secondary to infectious pleural effusion. All patients will performed spirometric studies at the beginning of the study, at 3 and 6 month.

Secondary Outcome Measures
NameTimeMethod
Change in resolution of pleural effusion3 months

To analysed if CP allows faster resolution of pleural effusion. A simple thoracic Rx will be performed to assess radiological changes every month till resolution of pleural sequelae.

Reduce hospital stay3 months

To assess if CP added to medical therapy in patients with infectious pleural effusion decreased hospital stay

Trial Locations

Locations (1)

Inmaculada Castillo

🇪🇸

Granollers, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath